Evidence map›Paper›PMID 39417860›Full record

Trial reportPsychopharmacology2025

Immediate effects of propofol on mood: a randomized comparison of two doses in a cohort with depression.

Daniel A Feldman, Keith G Jones, Lily C Vonesh, Rebecca Jacobs, Nathan Hoffman, Carter Lybbert, Jason Huang, Kai Kuck, David Odell, Scott C Tadler and 1 more

Abstract readClinical Trial, Phase IIClinical Trial, Phase IIIComparative Study
PubMed Publisher
In one paragraph

Trial report in Psychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Daniel A FeldmanDepartment of Psychiatry, Huntsman Mental Health Institute, University of Utah, Salt Lake City, Utah, USA. daniel.a.feldman@utah.edu.
Keith G JonesDepartment of Psychiatry, Huntsman Mental Health Institute, University of Utah, Salt Lake City, Utah, USA.
Lily C VoneshDepartment of Psychiatry, Huntsman Mental Health Institute, University of Utah, Salt Lake City, Utah, USA.
Rebecca JacobsDepartment of Psychiatry, Huntsman Mental Health Institute, University of Utah, Salt Lake City, Utah, USA.
Nathan HoffmanDepartment of Psychiatry, Huntsman Mental Health Institute, University of Utah, Salt Lake City, Utah, USA.
Carter LybbertDepartment of Biomedical Engineering, University of Utah, Salt Lake City, Utah, USA.
Jason HuangDepartment of Biomedical Engineering, University of Utah, Salt Lake City, Utah, USA.
Kai KuckDepartment of Biomedical Engineering, University of Utah, Salt Lake City, Utah, USA.
David OdellDepartment of Anesthesiology, University of Utah, Salt Lake City, Utah, USA.
Scott C TadlerDepartment of Psychiatry, Huntsman Mental Health Institute, University of Utah, Salt Lake City, Utah, USA.
Brian J MickeyDepartment of Psychiatry, Huntsman Mental Health Institute, University of Utah, Salt Lake City, Utah, USA. brian.mickey@utah.edu.ORCID http://orcid.org/0000-0002-7847-7680

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
NCATS NIH HHS UL1TR002538
6 · The paper itself

Abstract

rationaleThe intravenous anesthetic propofol is known to induce positive mood effects during routine clinical use, suggesting it might be repurposed as an antidepressant, but also raising concerns about abuse potential. How propofol's acute effects vary by dose and with repeated infusions is unknown.

objectivesThis exploratory analysis aimed to (1) compare the immediate mood effects of propofol administered at two different doses, (2) describe how those mood effects change with repeated infusions, and (3) evaluate whether acute mood improvement predicts later antidepressant response.

methodsTwenty-four adults with moderate-to-severe treatment-resistant depression were randomized into two dosing groups. Six low- or high-dose propofol infusions were administered under blinded conditions over a two-week period. Self-reported mood states were recorded before and after each infusion using the Positive and Negative Affect Schedule (PANAS-X). Abuse potential was evaluated with the Drug Effects Questionnaire (DEQ-5).

resultsAt the first infusion, propofol induced acute improvements in PANAS-X Sadness, Fear, Joviality, and Serenity scales (p < 0.002), independent of dose. Over the series of six infusions, acute changes in Sadness, Fear, and Joviality, but not Serenity, diminished with infusion number (p < 0.002). The DEQ-5 "want more" rating decreased across infusions (p = 0.002). Changes in PANAS-X scales with the first infusion did not predict later improvement in depression severity (p > 0.05).

conclusionCumulative changes in mood states observed with repeated infusions suggest that propofol engages adaptive mechanisms in mood circuitry. Subjective responses with repeated infusions do not indicate increasing potential for abuse in this patient population.

Indexed as

AffectAnesthetics, IntravenousAntidepressive AgentsDepressive Disorder, Treatment-ResistantPropofolAdultCohort StudiesCross-Over StudiesDose-Response Relationship, DrugFemaleHumansInfusions, IntravenousMaleMiddle AgedAnesthetics, IntravenousAntidepressive AgentsPropofolAnestheticAntidepressantDepressionMoodPropofol

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.